Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2013-10-18

FDA Approved: BUTALBITAL, ACETAMINOPHEN AND CAFFEINE — Supplemental Application (Strides Pharma Science Limited)

View source ↗

Summary

FDA approved a supplemental application for the generic combination drug butalbital, acetaminophen and caffeine manufactured by Strides Pharma Science Limited.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (butalbital; acetaminophen; caffeine)

Snippet

SUPPL AP for BUTALBITAL, ACETAMINOPHEN AND CAFFEINE (BUTALBITAL, ACETAMINOPHEN, AND CAFFEINE)